Cephalexin in pharma franchise in West Bengal

Cephalexin in PCD pharma franchise in Amaravati

Cephalexin in top pharma company in Bharatpur

Cephalexin in pcd pharma supplier in Raigarh

Cephalexin in phama franchise company in India
Cephalexin in phama distributor in Chhindwara

Home/Products /cephalexin-i-point-p-point-250mg-tablet

Fixolexin 250 DT Tablet

Composition : Cephalexin (250mg) DT

Dosage Form : Tablet

Packaging Type : Alu strip

Packaging : 10*10

Price : ₹149/-

Fixolexin 250 DT Tablet contains Cephalexin I.P. 250mg, a first-generation cephalosporin antibiotic. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. This medication is widely used to combat a variety of bacterial infections and is particularly effective against Gram-positive organisms and certain Gram-negative bacteria. Its broad-spectrum action makes it a reliable choice for managing infections.

Fixolexin 250 DT Tablet is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, ear infections (otitis media), and bone infections caused by susceptible bacteria. It provides effective relief by targeting the source of infection and halting bacterial growth. Its convenient tablet form ensures easy administration and consistent dosing for adult and pediatric patients as prescribed.

The tablet formulation is well-absorbed in the gastrointestinal tract and begins working shortly after ingestion. Fixolexin 250 Tablet is particularly beneficial in outpatient settings, ensuring effective management of infections without the need for intravenous administration. This antibiotic is best used under medical supervision to ensure optimal efficacy and safety.

Read More

About the Product

Fixolexin 250 DT Tablet contains Cephalexin I.P. 250mg, a first-generation cephalosporin antibiotic. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. This medication is widely used to combat a variety of bacterial infections and is particularly effective against Gram-positive organisms and certain Gram-negative bacteria. Its broad-spectrum action makes it a reliable choice for managing infections.

Fixolexin 250 DT Tablet is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, ear infections (otitis media), and bone infections caused by susceptible bacteria. It provides effective relief by targeting the source of infection and halting bacterial growth. Its convenient tablet form ensures easy administration and consistent dosing for adult and pediatric patients as prescribed.

The tablet formulation is well-absorbed in the gastrointestinal tract and begins working shortly after ingestion. Fixolexin 250 Tablet is particularly beneficial in outpatient settings, ensuring effective management of infections without the need for intravenous administration. This antibiotic is best used under medical supervision to ensure optimal efficacy and safety.

Common side effects include nausea, vomiting, diarrhea, and allergic reactions like rashes or itching. Serious side effects, though rare, may include severe allergic reactions or Clostridioides difficile-associated diarrhea.

Fixolexin 250 Tablet is indicated for bacterial infections, including respiratory tract infections, UTIs, otitis media, skin and soft tissue infections, and bone infections.

Use only under medical supervision. Do not use if allergic to cephalosporins or penicillins. Complete the full course of treatment to prevent antibiotic resistance.

Store at 15-30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation